Malignant hyperthermia is a potentially fatal syndrome requiring early recognition and prompt medical intervention during anesthesia.
Answers are grounded in this paper and cite their sources.
Emphasizes MH preparedness in all anesthetizing locations; leaves open the impact of modern protocols on current incidence and mortality.
The true incidence of malignant hyperthermia is unknown, but the frequency has been estimated as high as 1/14,000 anesthetic events. Review of the literature reports mortality rates up to 70%. Without prompt medical intervention, it is a uniformly fatal disease. Thus, it behooves the physician to have an awareness of the syndrome and its features, so that early recognition and adequate treatment take place. This paper presents a review of the literature on the occurrence, pathology, symptoms and treatment of malignant hyperthermia.
No takes yet. Share an insight, caveat, or question.
Jaffe et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: